Exact Sciences [EXAS] vs Agilent Technologies [A] Detailed Stock Comparison

Exact Sciences

NASDAQ
Loading...

Agilent Technologies

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Exact Sciences wins in 7 metrics, Agilent Technologies wins in 12 metrics, with 0 ties. Agilent Technologies appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricExact SciencesAgilent TechnologiesBetter
P/E Ratio (TTM)-10.1533.02Exact Sciences
Price-to-Book Ratio4.356.31Exact Sciences
Debt-to-Equity Ratio102.7356.42Agilent Technologies
PEG Ratio0.111.53Exact Sciences
EV/EBITDA158.6122.97Agilent Technologies
Profit Margin (TTM)-34.19%17.97%Agilent Technologies
Operating Margin (TTM)0.34%23.19%Agilent Technologies
EBITDA Margin (TTM)0.34%23.19%Agilent Technologies
Return on Equity-35.51%19.88%Agilent Technologies
Return on Assets (TTM)-1.39%8.35%Agilent Technologies
Free Cash Flow (TTM)$74.55M$1.37BAgilent Technologies
Dividend YieldN/A0.85%N/A
1-Year Return-18.79%-1.54%Agilent Technologies
Price-to-Sales Ratio (TTM)3.655.92Exact Sciences
Enterprise Value$12.42B$42.21BAgilent Technologies
EV/Revenue Ratio4.226.22Exact Sciences
Gross Profit Margin (TTM)69.35%51.09%Exact Sciences
Revenue per Share (TTM)$16$24Agilent Technologies
Earnings per Share (Diluted)$-5.45$4.29Agilent Technologies
Beta (Stock Volatility)1.241.26Exact Sciences
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Exact Sciences vs Agilent Technologies Stock Performance Analysis

Loading Price Chart...

Exact Sciences
Agilent Technologies
Exact Sciences Stock Overview | Agilent Technologies Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Exact Sciences1.60%7.96%6.94%9.81%31.49%1.23%
Agilent Technologies-0.02%14.43%10.52%18.75%36.70%6.13%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Exact Sciences-18.79%89.88%-44.22%621.28%548.99%2,738.92%
Agilent Technologies-1.54%12.66%32.72%295.78%474.25%540.19%

News Based Sentiment: Exact Sciences vs Agilent Technologies

Exact Sciences

News based Sentiment: MIXED

Exact Sciences reported strong first-quarter revenue growth, but simultaneously lowered its full-year guidance. This combination of positive and negative developments creates a mixed investment narrative, suggesting both opportunities and potential challenges for investors.

View Exact Sciences News Sentiment Analysis

Agilent Technologies

News based Sentiment: POSITIVE

Agilent delivered a strong Q3 earnings report, exceeding revenue expectations and receiving multiple analyst upgrades and price target increases. Strategic partnerships and continued innovation further strengthen the investment case, indicating a positive trajectory for the company.

View Agilent Technologies News Sentiment Analysis

Performance & Financial Health Analysis: Exact Sciences vs Agilent Technologies

MetricEXASA
Market Information
Market Cap i$10.74B$40.16B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i2,085,3001,888,910
90 Day Avg. Volume i2,552,0671,942,390
Last Close$57.63$141.61
52 Week Range$38.81 - $72.83$96.43 - $153.84
% from 52W High-20.87%-7.95%
All-Time High$159.54 (Jan 25, 2021)$179.57 (Aug 30, 2021)
% from All-Time High-63.88%-21.14%
Growth Metrics
Quarterly Revenue Growth0.16%0.10%
Quarterly Earnings Growth0.16%0.19%
Financial Health
Profit Margin (TTM) i-0.34%0.18%
Operating Margin (TTM) i0.00%0.23%
Return on Equity (TTM) i-0.36%0.20%
Debt to Equity (MRQ) i102.7356.42
Cash & Liquidity
Book Value per Share (MRQ)$13.05$22.46
Cash per Share (MRQ)$4.53$5.41
Operating Cash Flow (TTM) i$305.61M$1.50B
Levered Free Cash Flow (TTM) i$140.26M$902.88M
Dividends
Last 12-Month Dividend Yield iN/A0.85%
Last 12-Month Dividend iN/A$0.98

Valuation & Enterprise Metrics Analysis: Exact Sciences vs Agilent Technologies

MetricEXASA
Price Ratios
P/E Ratio (TTM) i-10.1533.02
Forward P/E i-166.8225.07
PEG Ratio i0.111.53
Price to Sales (TTM) i3.655.92
Price to Book (MRQ) i4.356.31
Market Capitalization
Market Capitalization i$10.74B$40.16B
Enterprise Value i$12.42B$42.21B
Enterprise Value Metrics
Enterprise to Revenue i4.226.22
Enterprise to EBITDA i158.6122.97
Risk & Other Metrics
Beta i1.241.26
Book Value per Share (MRQ) i$13.05$22.46

Financial Statements Comparison: Exact Sciences vs Agilent Technologies

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)EXASA
Revenue/Sales i$706.79M$1.67B
Cost of Goods Sold i$206.24M$802.00M
Gross Profit i$500.55M$866.00M
Research & Development i$105.31M$112.00M
Operating Income (EBIT) i$-89.76M$300.00M
EBITDA i$-36.86M$362.00M
Pre-Tax Income i$-100.99M$260.00M
Income Tax i$224,000$45.00M
Net Income (Profit) i$-101.22M$215.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)EXASA
Cash & Equivalents i$347.13M$1.49B
Total Current Assets i$1.37B$4.21B
Total Current Liabilities i$502.47M$2.01B
Long-Term Debt i$2.49B$3.35B
Total Shareholders Equity i$2.40B$6.14B
Retained Earnings i$-4.60B$912.00M
Property, Plant & Equipment i$126.66MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)EXASA
Operating Cash Flow i$-36.98M$178.00M
Capital Expenditures i$-31.17M$-114.00M
Free Cash Flow i$-365,000$107.00M
Debt Repayment i$-249.17M$0
Common Stock Repurchase iN/A$-165.00M

Short Interest & Institutional Ownership Analysis

MetricEXASA
Shares Short i8.09M3.20M
Short Ratio i2.761.81
Short % of Float i0.05%0.01%
Average Daily Volume (10 Day) i2,085,3001,888,910
Average Daily Volume (90 Day) i2,552,0671,942,390
Shares Outstanding i185.62M285.19M
Float Shares i187.46M282.49M
% Held by Insiders i0.01%0.00%
% Held by Institutions i0.96%0.93%

Dividend Analysis & Yield Comparison: Exact Sciences vs Agilent Technologies

MetricEXASA
Last 12-Month Dividend iN/A$0.98
Last 12-Month Dividend Yield iN/A0.85%
3-Year Avg Annual Dividend iN/A$0.86
3-Year Avg Dividend Yield iN/A0.18%
3-Year Total Dividends iN/A$2.57
Ex-Dividend DateN/AApr 01, 2025